Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?

被引：35
作者：
Bresalier, Robert S. [1 ]
Kopetz, Scott [2 ]
Brenner, Dean E. [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA
[3] Univ Michigan, Dept Med Oncol, Ann Arbor, MI 48109 USA
来源：
DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 03期
关键词：
Colon cancer; Screening; Blood-based markers; Fecal occult blood testing; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED ANTIGEN; SEPTIN; 9; DNA; COLON-CANCER; GLYCOPROTEIN MICROARRAYS; BINDING PROTEIN-3; POTENTIAL MARKER; PLASMA-INSULIN; FACTOR-I; SERUM;
D O I：
10.1007/s10620-015-3575-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10 % of the total cancer burden with an individual lifetime risk of similar to 6 % in the USA (Siegel et al. in CA Cancer J Clin 62:9-29, 2014, American Cancer Society in Colorectal cancer facts and figures 2011-2013. American Cancer Society, Atlanta, 2011, Siegel et al. in CA Cancer J Clin 61:212-236, 2011). Although numerous screening methods have been incorporated into guidelines for colorectal cancer screening, no guideline includes a noninvasive blood-based test as a recommended option.
引用
收藏
页码：664 / 671
页数：8
相关论文
共 66 条
  • [51] Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature
    Sanduleanu, S.
    le Clercq, C. M. C.
    Dekker, E.
    Meijer, G. A.
    Rabeneck, L.
    Rutter, M. D.
    Valori, R.
    Young, G. P.
    Schoen, R. E.
    [J]. GUT, 2015, 64 (08) : 1257 - U203
  • [52] Scanlan MJ, 2002, CANCER RES, V62, P4041
  • [53] The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
    Siegel, Rebecca
    Ward, Elizabeth
    Brawley, Otis
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (04) : 212 - 236
  • [54] Souverijn JHM, 2014, NEW ENGL J MED, V371, P187, DOI [10.1056/NEJMc1405215, 10.1056/NEJMoa1311194]
  • [55] On the Development of Plasma Protein Biomarkers
    Surinova, Silvia
    Schiess, Ralph
    Huettenhain, Ruth
    Cerciello, Ferdinando
    Wollscheid, Bernd
    Aebersold, Ruedi
    [J]. JOURNAL OF PROTEOME RESEARCH, 2011, 10 (01) : 5 - 16
  • [56] Takeda A, 2000, ONCOL REP, V7, P333
  • [57] Sensitivity Estimates of Blood-Based Tests for Colorectal Cancer Detection: Impact of Overrepresentation of Advanced Stage Disease
    Tao, Sha
    Hundt, Sabrina
    Haug, Ulrike
    Brenner, Hermann
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (02) : 242 - 253
  • [58] Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers
    Toth, Kinga
    Sipos, Ferenc
    Kalmar, Alexandra
    Patai, Arpad V.
    Wichmann, Barnabas
    Stoehr, Robert
    Golcher, Henriette
    Schellerer, Vera
    Tulassay, Zsolt
    Molnar, Bela
    [J]. PLOS ONE, 2012, 7 (09):
  • [59] Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group
    Tuck, Melissa K.
    Chan, Daniel W.
    Chia, David
    Godwin, Andrew K.
    Grizzle, William E.
    Krueger, Karl E.
    Rom, William
    Sanda, Martin
    Sorbara, Lynn
    Stass, Sanford
    Wang, Wendy
    Brenner, Dean E.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2009, 8 (01) : 113 - 117
  • [60] Cancer Genome Landscapes
    Vogelstein, Bert
    Papadopoulos, Nickolas
    Velculescu, Victor E.
    Zhou, Shibin
    Diaz, Luis A., Jr.
    Kinzler, Kenneth W.
    [J]. SCIENCE, 2013, 339 (6127) : 1546 - 1558
1234567